- Rapid inhibition of difficult to treat cancer cell lines.
- Reproducible cell viability/dose response curves.
- Mechanism consistent with activation of apoptotic pathway.
- Physico-chemical properties consistent with high oral absorption and BBB (Blood-brain barrier) permeability.
- Pharmacokinetics, ADME (Absorption, Distribution, Metabolism, Excretion), likely simple and efficient.
- Metabolism most probably through decarboxylation.
CRO toxicology, pre-IND meeting with FDA, human clinical trials (Phase I or Phase I/II hybrid) - as soon as $$$ are available. Let's save lives!
Contact me if you can be of assistance with finances to expedite this process. Thank you.